Incysus enters clinical trial for genetically-modified T cells for treating glioblastoma
https://informaconnect.com/biotech-showcase/ Lawrence Lamb, Executive VP and Chief Scientific Officer at Incysus Therapeutics, tells an inspirational story ...
Biotech Showcase
Immunology Comprehensive Revision (gamma-delta T cells & NKT) Lecture 10
Immunological.
Dr. Malabika Bhattacharjee
Gamma delta T Zellen Teil 1
Immundefekt.de
The exhausted T-cell - Josephine Giles
Convergence Immunology Project Meeting Topic: The exhausted T-cell Speaker: Josephine Giles Date: April 29, 2017 For more info, please visit ...
Institute for Advanced Study
VerEvMed's Dr Guerra explains how gamma delta T lymphocytes are controlled by isoprenoids
Prof Guerra of VerEvMed discusses new research on gamma delta T lymphocyte switching is controlled by phosphoisoprenoid metabolism. Feb 2018.
DJ Guerra
Warren Buffett: How To Invest For Beginners
In this video we get Warren Buffett to show you 7 investing principles that he has used to get high returns. If you're a beginner in the stock market I would highly ...
Cooper Academy - Investing
T-Regulatory Cells In Tumor Progression And Therapy- Video Abstract ID 228887
Video abstract of review paper “T-Regulatory Cells In Tumor Progression And Therapy” published in the open access journal Cancer Management and ...
Dove Medical Press
Partnering With Genmab
We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine. We are Janssen.
Janssen Global
THE CHAIN: Episode 5 - Hot Topics in Continuous Chromatography w/ Dr. Massimo Morbidelli
Dr. Massimo Morbidelli is giving the Keynote Presentation in the “Protein Purification Technologies” conference that's part of CHI's 11th annual PEGS Summit ...
CII
Antibody Engineering 2016 Interview: Paul Parren, Genmab
At Antibody Engineering & Therapeutics 2016 in San Diego, CA, we sat down with Paul Parren, Ph.D., Senior Vice President and Scientific Director at Genmab.
Informa Connect Life Sciences
Organizer Interview: Paul W.H.I. Parren, PhD
Organizer Interview: Paul W.H.I. Parren, PhD Paul W.H.I. Parren, PhD, Professor at Leiden University Medical Center, discusses the February 25-March 1, 2018 ...
KeystoneSymposia
TC BioPharm - safe CAR T therapy based on gamma delta T cells
https://life-science-animation.com/ Chimeric antigen receptors, or CARs, are a promising approach to cancer therapy that uses human T-cells. In conventional ...
Life Science Animation